Literature DB >> 24247244

A new paradigm for enzymatic control of α-cleavage and β-cleavage of the prion protein.

Alex J McDonald1, Jessie P Dibble, Eric G B Evans, Glenn L Millhauser.   

Abstract

The cellular form of the prion protein (PrP(C)) is found in both full-length and several different cleaved forms in vivo. Although the precise functions of the PrP(C) proteolytic products are not known, cleavage between the unstructured N-terminal domain and the structured C-terminal domain at Lys-109↓His-110 (mouse sequence), termed α-cleavage, has been shown to produce the anti-apoptotic N1 and the scrapie-resistant C1 peptide fragments. β-Cleavage, residing adjacent to the octarepeat domain and N-terminal to the α-cleavage site, is thought to arise from the action of reactive oxygen species produced from redox cycling of coordinated copper. We sought to elucidate the role of key members of the ADAM (a disintegrin and metalloproteinase) enzyme family, as well as Cu(2+) redox cycling, in recombinant mouse PrP (MoPrP) cleavage through LC/MS analysis. Our findings show that although Cu(2+) redox-generated reactive oxygen species do produce fragmentation corresponding to β-cleavage, ADAM8 also cleaves MoPrP in the octarepeat domain in a Cu(2+)- and Zn(2+)-dependent manner. Additional cleavage by ADAM8 was observed at the previously proposed location of α-cleavage, Lys-109↓His-110 (MoPrP sequencing); however, upon addition of Cu(2+), the location of α-cleavage shifted by several amino acids toward the C terminus. ADAM10 and ADAM17 have also been implicated in α-cleavage at Lys-109↓His-110; however, we observed that they instead cleaved MoPrP at a novel location, Ala-119↓Val-120, with additional cleavage by ADAM10 at Gly-227↓Arg-228 near the C terminus. Together, our results show that MoPrP cleavage is far more complex than previously thought and suggest a mechanism by which PrP(C) fragmentation responds to Cu(2+) and Zn(2+).

Entities:  

Keywords:  ADAM; Alzheimer Disease; Copper; Enzyme; Metalloproteinase; Neurodegeneration; Prion Protein Proteolysis; Prions; Zinc

Mesh:

Substances:

Year:  2013        PMID: 24247244      PMCID: PMC3887206          DOI: 10.1074/jbc.M113.502351

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

1.  Cleavage of the amino terminus of the prion protein by reactive oxygen species.

Authors:  H E McMahon; A Mangé; N Nishida; C Créminon; D Casanova; S Lehmann
Journal:  J Biol Chem       Date:  2000-11-01       Impact factor: 5.157

2.  Copper in Alzheimer disease: too much, too little, or misplaced?

Authors:  Peter Faller
Journal:  Free Radic Biol Med       Date:  2011-11-11       Impact factor: 7.376

3.  Recombinant prion protein induces rapid polarization and development of synapses in embryonic rat hippocampal neurons in vitro.

Authors:  Jamil Kanaani; Stanley B Prusiner; Julia Diacovo; Steinunn Baekkeskov; Giuseppe Legname
Journal:  J Neurochem       Date:  2005-12       Impact factor: 5.372

4.  Cellular prion protein regulates its own α-cleavage through ADAM8 in skeletal muscle.

Authors:  Jingjing Liang; Wei Wang; Debra Sorensen; Sarah Medina; Sergei Ilchenko; Janna Kiselar; Witold K Surewicz; Stephanie A Booth; Qingzhong Kong
Journal:  J Biol Chem       Date:  2012-03-23       Impact factor: 5.157

5.  Zinc drives a tertiary fold in the prion protein with familial disease mutation sites at the interface.

Authors:  Ann R Spevacek; Eric G B Evans; Jillian L Miller; Heidi C Meyer; Jeffrey G Pelton; Glenn L Millhauser
Journal:  Structure       Date:  2013-01-03       Impact factor: 5.006

6.  Protein production by auto-induction in high density shaking cultures.

Authors:  F William Studier
Journal:  Protein Expr Purif       Date:  2005-05       Impact factor: 1.650

7.  Truncated forms of the human prion protein in normal brain and in prion diseases.

Authors:  S G Chen; D B Teplow; P Parchi; J K Teller; P Gambetti; L Autilio-Gambetti
Journal:  J Biol Chem       Date:  1995-08-11       Impact factor: 5.157

8.  Active-site determinants of substrate recognition by the metalloproteinases TACE and ADAM10.

Authors:  Cristina I Caescu; Grace R Jeschke; Benjamin E Turk
Journal:  Biochem J       Date:  2009-10-23       Impact factor: 3.857

9.  The PrP(C) C1 fragment derived from the ovine A136R154R171PRNP allele is highly abundant in sheep brain and inhibits fibrillisation of full-length PrP(C) protein in vitro.

Authors:  Lauren Campbell; Andrew C Gill; Gillian McGovern; Clara M O Jalland; John Hopkins; Michael A Tranulis; Nora Hunter; Wilfred Goldmann
Journal:  Biochim Biophys Acta       Date:  2013-03-06

10.  Chronic wasting disease of captive mule deer: a spongiform encephalopathy.

Authors:  E S Williams; S Young
Journal:  J Wildl Dis       Date:  1980-01       Impact factor: 1.535

View more
  42 in total

1.  Shedding light on prion disease.

Authors:  Markus Glatzel; Luise Linsenmeier; Frank Dohler; Susanne Krasemann; Berta Puig; Hermann C Altmeppen
Journal:  Prion       Date:  2015       Impact factor: 3.931

2.  Application of high-throughput, capillary-based Western analysis to modulated cleavage of the cellular prion protein.

Authors:  Andrew R Castle; Nathalie Daude; Sabine Gilch; David Westaway
Journal:  J Biol Chem       Date:  2018-12-21       Impact factor: 5.157

3.  PrP-grafted antibodies bind certain amyloid β-protein aggregates, but do not prevent toxicity.

Authors:  David Mengel; Wei Hong; Grant T Corbett; Wen Liu; Alexandra DeSousa; Laura Solforosi; Cheng Fang; Matthew P Frosch; John Collinge; David A Harris; Dominic M Walsh
Journal:  Brain Res       Date:  2018-12-26       Impact factor: 3.252

4.  Prion protein "gamma-cleavage": characterizing a novel endoproteolytic processing event.

Authors:  Victoria Lewis; Vanessa A Johanssen; Peter J Crouch; Genevieve M Klug; Nigel M Hooper; Steven J Collins
Journal:  Cell Mol Life Sci       Date:  2015-08-23       Impact factor: 9.261

5.  Cellular prion protein targets amyloid-β fibril ends via its C-terminal domain to prevent elongation.

Authors:  Erin Bove-Fenderson; Ryo Urano; John E Straub; David A Harris
Journal:  J Biol Chem       Date:  2017-08-23       Impact factor: 5.157

6.  Intrinsic toxicity of the cellular prion protein is regulated by its conserved central region.

Authors:  Graham P Roseman; Bei Wu; Mark A Wadolkowski; David A Harris; Glenn L Millhauser
Journal:  FASEB J       Date:  2020-05-08       Impact factor: 5.191

7.  Fluorescein-N-Methylimidazole Conjugate as Cu(2+) Sensor in Mixed Aqueous Media Through Electron Transfer.

Authors:  Aasif Helal; Hong-Seok Kim; Zain H Yamani; M Nasiruzzaman Shaikh
Journal:  J Fluoresc       Date:  2015-11-14       Impact factor: 2.217

Review 8.  Prions and prion diseases: Insights from the eye.

Authors:  Neena Singh; Suman Chaudhary; Ajay Ashok; Ewald Lindner
Journal:  Exp Eye Res       Date:  2020-08-25       Impact factor: 3.467

Review 9.  PrP overdrive: does inhibition of α-cleavage contribute to PrP(C) toxicity and prion disease?

Authors:  Alex J McDonald; Glenn L Millhauser
Journal:  Prion       Date:  2014-04-10       Impact factor: 3.931

10.  Interaction between Prion Protein's Copper-Bound Octarepeat Domain and a Charged C-Terminal Pocket Suggests a Mechanism for N-Terminal Regulation.

Authors:  Eric G B Evans; M Jake Pushie; Kate A Markham; Hsiau-Wei Lee; Glenn L Millhauser
Journal:  Structure       Date:  2016-06-02       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.